Efficient method for the isolation by HPLC, of a major metabolite of the carcinogen 2-amino-3-methylimidazo [4,5-f]quinoline (IQ), the 5-hydroxy derivative.
Previous difficulties in the standard HPLC separation of the 5-hydroxy derivative, a major metabolite of the food mutagen and carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), with the properties of a chelating agent, were resolved by utilizing a nonmetallic tubing and column and a BRP-1 stationary phase. This system separates the already known metabolites by reverse phase mode, but presents the unique advantage of resolving chelating compounds like 5-hydroxy-IQ as a single, clean peak. The procedure may be generally applicable to this class of chemicals.